MedPath
NMPA Approval

Loteprednol Etabonate Ophthalmic Suspension

国药准字HJ20160347

November 4, 2024

H20160347

Drug Information

氯替泼诺混悬滴眼液

露达舒

眼用制剂

0.5%(10ml:50mg,15ml:75mg)

化学药品

November 4, 2024

November 3, 2029

Company Information

Applicant Company

400 Somerset Corporate Blvd, Bridgewater, NJ 08807 USA

Manufacturing Company

8500 Hidden River Parkway, Tampa, Florida 33637, USA

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

氯替泼诺混悬滴眼液 - NMPA 批准文号 | MedPath